Companies in the biopharma sector developing innovative solutions and technologies.
Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.
Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.
PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Living In Silico offers biotechnology products and services using computer-based simulations.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
Systemic Bio creates bioprinted organs-on-chips for drug discovery and development.
Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.
Sonoran Biosciences is an early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier.
Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
TopoDx is a biotechnology company that offers a microbial test to identify antibiotic resistance and susceptibility accurately.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
A clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies.
ClostraBio is a biopharma company developing therapeutics for food allergies.
Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked